Featured Resources
49:25
Automation of Glycan and Peptide Mapping and Improving Efficiency and Quality

More samples, more tests and more complex modalities. Sound familiar? As Pfizer increased the number of assays to perform, Thomas Powers underscores that it is also critical to automate original routine assays and describes challenges tackled along the path.

56:09
How to Advance Your Host Cell Protein Analysis with Mass Spectrometry

What problem HCPs should you look for? When to implement MS analysis of HCPs in product development? How to use MS to complement other analytical techniques? Kevin van Cott has the answers...

29:04
Why don't we monitor drug product profile directly?

What's in that reactor? How do we use informatics to better design monitor and control the process. Having a clear idea of your design space gives you the ability to operate within it.

37:22
EU UGM 2022 – Structural Determinants Regulating Viral Spike Glycosylation and Biomolecular Interactions

Weston Strewe explores the structural biophysics of host-pathogen interactions and how glycosylation effects in viral infection

34:46
High throughput screening and data analysis using Native Mass Spectrometry and Byos

Under carefully optimized instrumental conditions it is feasible to quantify the drug dissociation constant (Kd). OMass Therapeutics presents in house high-throughput native MS screening platform combined with high-throughput data processing.

27:36
EU UGM 2023: Impurity Characterisation of modified siRNA using Byos Oligo Workflow

Straight forward and intuitive Monoisotopic deconvolution is robust for chemically modified oligos

46:12
Spotting the Outliers and New Peaks in MAM Runs Automatically

Unified data processing makes it easier to compare data within Dashboards and get the most out of your MAM results with no extra effort or pain

posters
published articles
Briefs
Insights
Download Information & system requirements
×